Bullous impetigo – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 05 Jun 2026 10:54:36 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Bullous impetigo – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Comparing two forms of mupirocin (gel and ointment) for treating impetigo in children: a study of different dosing schedules https://clinicaltrials.eu/trial/comparing-two-forms-of-mupirocin-gel-and-ointment-for-treating-impetigo-in-children-a-study-of-different-dosing-schedules/ Wed, 29 Apr 2026 15:06:29 +0000 https://clinicaltrials.eu/trial/comparing-two-forms-of-mupirocin-gel-and-ointment-for-treating-impetigo-in-children-a-study-of-different-dosing-schedules/ This clinical trial focuses on treating impetigo, which is a common bacterial skin infection that primarily affects children. The study compares two different forms of the same medication containing mupirocin – Impetine® Gel and Bactroban® Ointment – both applied directly to the skin to treat the infection.

The purpose of this research is to determine if using Impetine® Gel twice per day works as effectively as Bactroban® Ointment used three times per day in treating impetigo in children. Both medications contain the same amount of the active ingredient (20 mg/g of mupirocin), but they come in different forms – one as a gel and the other as an ointment.

The treatment period lasts for 7 days, during which participants will apply their assigned medication to the affected skin areas. The study will monitor how well the skin infection heals and check for any side effects. Doctors will examine the treated areas and evaluate the healing process using a special scoring system that looks at various signs of infection.

]]>